HRB 14625: Seracell Pharma GmbH
, Rostock, Schillingallee 68, 18057 Rostock
. The company is merged as the acquiring entity with the Seracell Stammzelltechnologie GmbH
with its registered office in Rostock (District Court of Rostock HRB 9342
) in accordance with the merger agreement of August 12, 2019 as well as the approval decisions of its shareholders' meeting of August 12, 2019 and the shareholders' meeting of the transferring entity of August 12, 2019. The creditors of the companies participating in the merger must be deemed to have declared their claim in writing in writing within six months of the date on which the registration of the merger in the register of the registered office of the entity of which they are creditors is deemed to have been made known in accordance with Paragraph 19 (3) of the UmwG, provided that they cannot claim satisfaction. However, creditors are only entitled to this right if they demonstrate that the merger jeopardises the fulfilment of their claim.